STATE STREET CORP

Position in GUTS — Fractyl Health, Inc.

CIK 93751 BOSTON, MA

Position in GUTS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$212,832

-$915,108 QoQ

Shares Held

464,700

-9.4% QoQ

Ownership

0.293%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 73.35915644501829.ToString("F0")% Shared 0.ToString("F0")% None 26.640843554981707.ToString("F0")%

Healthcare · as of Mar 31, 2026

STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. GUTS ranks #347 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,730,139	$5,237,976,269
2	REGN	Regeneron Pharmaceuticals, Inc.	4,664,478	$3,603,962,281
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,322,698	$1,099,381,087
4	INSM	INSMED Inc	5,551,699	$907,813,820
5	INCY	Incyte Corp	9,641,384	$907,447,062
6	MRNA	Moderna, Inc.	14,861,409	$754,959,577
7	RPRX	Royalty Pharma plc	10,989,851	$527,183,152
8	ROIV	Roivant Sciences Ltd.	16,186,613	$448,369,180

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$212,832	464,700	-9.4%	Shares	Defined	2026-05-15
2025-12-31	$1,127,940	512,700	+1156.6%	Shares	Defined	2026-02-13
2025-09-30	$64,872	40,800	0.0%	Shares	Defined	2025-11-14
2025-06-30	$66,096	40,800	-75.0%	Shares	Defined	2025-08-14
2025-03-31	$193,967	162,998	-1.5%	Shares	Defined	2025-05-15
2024-12-31	$340,719	165,398	+45.8%	Shares	Defined	2025-02-14
2024-09-30	$286,939	113,415	+129.4%	Shares	Defined	2024-11-14
2024-06-30	$211,138	49,447	+67.1%	Shares	Defined	2024-08-14
2024-03-31	$219,040	29,600	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.